GC
ZBH icon

Gould Capital’s Zimmer Biomet ZBH Stock Holding History

Gould Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18
Closed -$1.64K – 221
2025
Q2 		$1.64K Buy
+18
New +$1.74K ﹤0.01% 188
2022
Q4 		– Sell
-10
Closed -$1K – 218
2022
Q3 		$1K Hold
10
– – ﹤0.01% 199
2022
Q2 		$1K Hold
10
– – ﹤0.01% 223
2022
Q1 		$1K Hold
10
– – ﹤0.01% 196
2021
Q4 		$1K Buy
+10
New +$1.31K ﹤0.01% 204

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gould Capital's ZBH Position: Q3 2025 in Review

Gould Capital sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 18 shares — an estimated $1.64K sold.

Gould Capital first reported a position in ZBH in Q4 2021 and held it in 5 quarters. The position peaked at $1.64K in Q2 2025. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Gould Capital reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Gould Capital sold 18 Zimmer Biomet shares in Q3 2025, an estimated $1.64K.
  • Gould Capital first reported a position in Zimmer Biomet in Q4 2021 and held it in 5 quarters.
  • Gould Capital's Zimmer Biomet position peaked at $1.64K in Q2 2025.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Gould Capital's 13F filing for Q3 2025, filed 17 Nov 2025.